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In Azores, the standardized mortality rate for coronary artery disease (CAD) is nearly the double when compared to mainland
Portugal. )e aim of this study was to compare the prevalence of conventional CAD risk factors, as well as the plasma aminothiol
profile (and its major determinants), between two groups of healthy subjects from Ponta Delgada (in Azores) and Lisbon (in
mainland) cities, searching for precocious biomarker(s) of the disease. )e study groups consisted of 101 healthy volunteers from
Ponta Delgada (PDL) and 121 from Lisbon, aged 20–69 years. No differences in the prevalence of classical CAD risk factors were
found between the study groups, except in physical inactivity and related central obesity, which were both higher in PDLmen than
in those from Lisbon. Hypercysteinemia, which seems to result from sulfur-rich amino acid diets and/or vitamin B12 malab-
sorption, revealed to be significantly more prevalent in PDL vs. Lisbon subjects (18% vs. 4%, P � 0.001), namely, in male gender.
Moreover, plasma Cys levels predicted waist circumference (β coefficient� 0.102, P � 0.032) and concomitant central obesity and
were also associated with insulin resistance. Nevertheless, hyperhomocysteinemia prevalence was similar in both groups, despite
the fact that PDL subjects exhibited a higher rate of vitamin B12 deficiency compared to those from Lisbon (19% vs. 6%, P � 0.003).
Owing to the nature of this study design, a cause-effect relationship between high plasma Cys levels and central obesity or CAD
risk could not be derived, but results strongly suggest that hypercysteinemia is a potential risk factor for metabolic disorders,
i.e., obesity and insulin resistance, and CAD in Azores, a hypothesis that asks for confirmation through further large
prospective studies.
1. Introduction
Atherosclerotic cardiovascular diseases (CVD) are the main
cause of death and disability in Portugal, where the Azores
islands still have the highest standardized mortality rate for
coronary artery disease (CAD), nearly twice the observed
one in mainland Portugal [1].
Atherosclerosis is a chronic, inflammatory, multifacto-
rial condition which can develop as a silent and progressive
disease, whose underlying mechanisms are complex and can
vary from one population to another [2]. Oxidative stress
plays a key role in atherogenesis since the beginning and all
along the progression of the pathology. It is defined as an
imbalance between the production of reactive oxygen spe-
cies (ROS) and their elimination by the antioxidant defense
systems, with a prevailing pro-oxidant status that results in
macromolecular damage and disruption of cellular redox
signaling. Oxidative stress is the unifying mechanism for
many CVD risk factors [3], such as obesity and diabetes
mellitus, and it also activates proinflammatory signaling
pathways. Since classical risk factors fail to account for part
of the CVD cases and oxidative stress can have a causal role
in these diseases [4], it is important to identify early,
noninvasive oxidative stress biomarkers in healthy pop-
ulations in order to define precociously subjects at high-risk
for CVD.
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Plasma aminothiols, such as homocysteine (Hcy),
cysteine (Cys), cysteinylglycine (Cys-Gly), and glutathione
(GSH), are actually seen as good markers for oxidative
stress [5]. All these species interact via redox, namely,
sulfide-disulfide exchange reactions, and their reduced,
oxidized, and protein-bound forms comprise a dynamic
system referred as the thiol redox status. )iol redox status
plays a central role in redox homeostasis, which is an
essential condition for normal cellular functions [6].
However, when in excessive amounts, total plasma Hcy
and Cys can have pro-oxidant effects, by producing ROS
and concomitant endothelial dysfunction, as well as
promoting LDL oxidation, thus favoring atherogenesis
[7, 8]. High Cys-Gly concentration can also disrupt the
thiol redox status in an iron-dependent manner [9]. On the
other hand, GSH is the major intracellular nonprotein
antioxidant [10].
Aminothiols are metabolically interrelated. Hcy is
produced from methionine (Met), an essential amino
acid, and can be remethylated to Met through the action
of methionine synthase, which requires vitamin B12 as a
cofactor and 5-methyltetrahydrofolate as a substrate.
Alternatively, Hcy can be transsulfurated to Cys by two
sequential vitamin B6-dependent reactions [11]. Besides
being an Hcy byproduct, Cys is a GSH precursor inside
cells. In turn, the action of gamma-glutamyltransferase
(GGT) on extracellular GSH produces glutamate and
Cys-Gly, which is usually taken within intracellular
milieu by membrane dipeptidases to form Cys and Gly as
precursors for GSH resynthesis. )erefore, the major
function of GGTactivity is to assist in antioxidant defense
[10].
Both high plasma Hcy and Cys and low GSH levels are
well-known conditions associated with atherosclerosis and
CVD [8, 12–14]. More recently, elevated plasma Cys con-
centrations have been suggested to have a causal role in
metabolic diseases, namely, in obesity, insulin resistance,
and diabetes mellitus [15, 16].
Plasma aminothiols content and redox state are de-
termined by both genetic and nutritional factors. )ese last
include the intake of sulfur amino acids (Cys and Met), the
availability of B-vitamins involved in their metabolism, and
the presence of dietary antioxidants (such as vitamins A, C,
and E) to inhibit oxidative processes and thereby contribute
to a more reduced redox state. Also lifestyle changes, such as
tobacco cessation, the practice of physical exercise, and
moderate consumption of alcohol contribute for a normal
aminothiol profile [17].
Taking into account that the Azores, an Atlantic,
Portuguese, volcanic origin archipelago formed by nine
islands has a higher mortality rate for CAD when com-
pared to mainland Portugal, we hypothesized that some
CVD risk factors could be highlighted in Azorean subjects.
)erefore, the aim of this study was to compare the
prevalence of standard, as well as some emerging CVD risk
factors, namely, the plasma aminothiol profile (and its
major determinants) between two groups of healthy
subjects from Ponta Delgada (PDL) and Lisbon cities,
respectively.
2. Subjects and Methods
2.1. Subjects and Study Design. )e study groups consisted
of 101 volunteers from Ponta Delgada city (in São Miguel
island, circa 68,000 inhabitants) and 121 from Lisbon city
(in mainland Portugal, 547,773 inhabitants). PDL sub-
jects were recruited in collaboration with Unidade de
Saúde de ilha de São Miguel (USISM) and those from
Lisbon were anonymized participants of the e_COR study
carried out by Instituto Nacional de Saúde Dr Ricardo
Jorge (INSA), between 2012 and 2015. All subjects were
caucasian, aged 20 to 69 years and gave a written in-
formed consent to participate in this study. )e study has
been performed in accordance with the ethical standards
laid down in the 1964 Declaration of Helsinki and its
latter amendments.
Participants were requested to answer a questionnaire on
their medical history, lifestyle information (physical activity
and alcohol and tobacco consumption), and medicine in-
take. Subjects with a history of CVD, diabetes mellitus, or
other chronic diseases, as well as those who were taking
vitamins supplements, were excluded from the study.
)is study had a cross-sectional design where subjects
were tested for standard CVD risk factors and for plasma
aminothiol content and its main circulating determinants
(plasma methionine, folate, vitamins B12, and B6 and GGT
activity).
2.2. Blood Collection. A single overnight 12 h fasting venous
blood sample was obtained from all subjects. )e blood was
drawn into 4.9ml vacutainer tubes with heparin or into
10ml tubes without anticoagulant. After centrifugation at
2,500× g for 15min at 4°C, plasma or serum were separated
and divided into 200 μl aliquots, freshly used or stored at
−80°C until HPLC analysis, as adequate.
2.3. Definition of Covariates (Risk Factors). Body weight and
height were measured to calculate body mass index (BMI)
and waist circumference. Global obesity was defined by a
BMI≥ 30 kg/m2. Central (or abdominal) obesity was defined
according to the NCEP/ATP III criteria [18] by a waist
circumference greater than 102 cm and 88 cm for men and
women, respectively. Smoking habits were considered when
subjects currently smoked or had stopped smoking in the
last year. Alcohol consumers were defined as alcohol intake
>0 g/day versus abstainers (�0 g/day). )e international
physical activity questionnaire (IPAQ) was used to assess
practitioners of physical activity (moderate plus active)
and nonpractitioners [19]. Hypertension was diagnosed
according to JNC-7 criteria [20] as blood pressure (BP)
higher than 140/90mmHg and/or the current use of anti-
hypertensive drugs. )e homeostasis model assessment of
insulin resistance (HOMA-IR) was calculated as follows:
fasting insulin (μU/mL)× fasting glucose (mmol/L)/22.5
and used as a measure of insulin sensitivity [21]. Subjects
with HOMA-IR≥ 2.73 (4th quartile) were considered as
insulin resistant. Dyslipidemia was defined according to the
NCEP/ATP III [18] criteria by high LDL cholesterol levels
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(LDL-c≥ 160mg/dL) and/or high triglycerides levels (TG≥
150mg/dL) and/or low HDL cholesterol levels (HDL-
c≤ 40mg/dL) and/or by the use of lipid-lowering drugs.
Hyperhomocysteinemia (HHcy) was defined as levels of
plasma homocysteine≥ 15 μM and hypercysteinemia (HCys)
as plasma Cys> 300 μM [8]. For vitamin B deficiencies, the
following usually considered cutoff points were employed:
serum folate< 3 ng/mL; vitamin B12< 200 pg/mL; and vita-
min B6< 7.4 ng/mL.
2.4. Biochemical Measurements. Blood parameters, such as
serum urea, uric acid, creatinine, glucose, GGTactivity, and
lipid profile, were determined in fresh samples by validated
standard laboratory methods. Total (i.e., the sum of re-
duced, oxidized, and free and protein-bound species)
plasma concentrations of Hcy, Cys, Cys-Gly, and GSH were
measured by a RP-HPLC methodology with fluorescence
detection (Exc. at 385 nm and Em. at 515 nm) and using a
platinum EPS C18 analytical column (53mm × 7mm I.D.,
3 μm particle size), according to the method described in
Ferin et al. [22] and already applied in Lima et al. [23]. )e
chromatographic analysis of the aminothiols was per-
formed by using 0.1M KH2PO4 (pH 2.0) containing
40mL·L−1 of ACN as the mobile phase, which allowed well-
resolved peaks of the individual compounds. )e tem-
perature of the column oven was maintained at 35°C that
shows the best resolution and shorter RT. )e flow rate of
1mL·min−1 was adopted in our study, which allowed in-
creased heights of the peaks and decreased their respective
width and RT. An aliquot of 20 μL was injected through a
Rheodyne injection valve after filtration through a 0.45 μm
PVDF filter. )e identification of four peaks was done by
comparison of the RTwith those corresponding to the pure
standards run separately in the same analytical conditions
and confirmed by spike of the authentic standards to the
plasma sample.
Plasma Met level was also determined by a RP-HPLC
method with fluorescence detection [24]. Serum insulin,
folate, and vitamin B12 concentrations were analyzed by
chemiluminescent microparticle immunoassay on an Ar-
chitect 2000 analyzer (Abbott Laboratories, USA). Plasma
pyridoxal-5′-phosphate level (the active circulating form of
vitamin B6) was determined by RP-HPLC with fluorescence
detection according to the method of Kimura et al. [25].
Serum retinol (vitamin A) and α-tocopherol (vitamin E)
concentrations were determined by an isocratic RP-HPLC-
UV method [26].
2.5. Sample SizeDetermination. Sample size was calculated a
posteriori to be 23 subjects in each of the two study groups
(N� 46), by using software G∗Power (University of Dus-
selldorf, Germany, version 3.1.9.2, http://www.gpower.hhu.
de/en.html), thus validating the final sample size used in this
work. )e parameters used for calculation were a mean
difference in plasma Cys of 50 μM between groups (as-
suming a standard deviation of also 50 μM) at the 5% level of
significance with 90% power.
2.6. Statistical Analysis. Results are expressed as mean±
standard deviation (SD) or frequencies as appropriate.
Variables were tested for normal distribution by using the
Kolmogorov–Smirnov test. Continuous variables were
compared by using the Student’s t-test if they were normally
distributed or the Mann–Whitney U test otherwise. Cate-
gorical variables were compared by using the Fisher exact
test or the chi-square test as appropriate. Correlations be-
tween selected pairs of variables were evaluated by using
Spearman’s rank correlation coefficient. To examine the
relationship among plasma Cys level or waist circumference
and other variables, linear regression analyses were per-
formed. Only the significant variables found at univariate
were considered for multivariate analysis. All analyses were
performed by using SPSS version 22.0 for Windows (SPSS
Inc., Chicago, IL). A 2-tailed P value <0.05 was considered
significant.
3. Results
3.1. Baseline Characterization of the Study Groups.
Demographic, clinical, and biochemical characteristics of
the study groups are described in Table 1. Both groups were
matched to age, gender, and BMI (P> 0.05). No differences
were observed between the groups regarding the prevalence
of conventional cardiovascular risk factors, such as global
obesity, menopause, smoking, and alcohol consumption, as
well as hypertension and dyslipidemia. However, men from
PDL revealed to have both higher waist circumference/
central obesity and a more sedentary life compared to
men from Lisbon. PDL subjects had lower diastolic BP and
higher levels of creatinine, glucose, and HOMA-IR score
compared to their counterparts from Lisbon, although the
latter parameter did not reach statistical significance when
analyzed by gender. )ere were no differences in serum
mean levels of urea, uric acid, and insulin, as well as in lipid
profile between the study groups, except in HDL-c con-
centrations. In fact, women from PDL had significantly
higher HDL-c concentrations compared to women from
Lisbon, where oral contraceptives users were less numerous.
PDL subjects (namely, the feminine gender) were also taking
more antiaggregant medication, but no differences between
groups were registered concerning statins and antihyper-
tensive drugs consumption.
3.2. Plasma Aminothiol Profile and Its Determinants in the
Study Groups. Table 2 shows the circulating concentrations
of aminothiols and their major determinants in the study
groups. In addition to individual thiol values, it also includes
their substrate/product ratios as indicators of the enzymatic
activities where they are involved: Hcy/Cys (cystathionine
β-synthase and cystathionine c-lyase), GSH/Cys-Gly
(c-glutamyl transferase), Cys/GSH (c-glutamyl-cysteine
synthetase or glutathione synthetase), and Met/Cys (rela-
tive to the transsulfuration pathway).
PDL subjects exhibited higher plasma levels of Cys,
Hcy, and Cys-Gly but similar GSH concentration com-
pared to those from Lisbon. It should be noted that plasma
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Cys was the aminothiol exhibiting by far the highest av-
erage concentration difference between the two groups
(about 28%, P< 0.001). )erefore, a clear higher prevalence
of hypercysteinemia was registered in PDL, namely, in male
gender, as compared to Lisbon group. Although Hcy mean
level was higher in PDL (namely, in feminine gender) than
in Lisbon subjects, no differences in the prevalence of
hyperhomocysteinemia between the study groups were
observed.
Significant lower Hcy/Cys and Met/Cys ratios were
found in PDL subjects, when compared to those from
Lisbon. However, no difference in GSH/Cys-Gly ratio (an
indirect measure of GGTactivity) was registered between the
study groups. Contrariwise, Cys/GSH ratio was significantly
higher in PDL vs. Lisbon group.
)e plasma concentration of Met, a major determinant
of plasma Cys level, did not differ between the study groups,
and it only correlated with vitamin B12 levels and tobacco use
(r� 0.17; P � 0.013, r�−0.18; P � 0.009, respectively). In
fact, PDL subjects exhibited less serum vitamin B12 andmore
folate levels compared to those from Lisbon, namely, in
feminine and male gender, respectively. Also, PDL subjects
revealed a higher frequency of vitamin B12 deficiency
compared to their counterparts. Diversely, plasma vitamin
B6 levels were similar in both groups.
No difference in GGT activity was observed between the
male groups, which is in accordance with their similar GSH/
Cys-Gly ratios. However, as compared to Lisbon, GGT ac-
tivity was significantly increased in PDL women, where GSH
would be expected to be decreased owing to the strong
inverse association observed between the two parameters
(r�−0.49, P< 0.001). Furthermore, GSH was the only
plasma aminothiol that was increased in women taking oral
contraceptives (2.28± 0.8 in users vs. 1.83± 0.6 μM in
nonusers, P � 0.007). Nevertheless, when removing oral
contraceptive users from analyses, there remained no dif-
ference in GSH level between the two feminine groups
(1.87± 0.5 vs. 1.82± 0.6 μM, P � 0.730). Also, GGT activity
did not differ between oral contraceptive users and non-
users.
3.3. Serum Antioxidant Fat-Soluble Vitamin Concentrations
in the Study Groups. Both serum α-tocopherol and retinol
concentrations were significantly lower in PDL than in
Lisbon group (8± 1mg/L in PDL vs. 9± 1mg/L in Lisbon;
Table 1: Demographic, clinical, and biochemical characteristics of subjects from Ponta Delgada (PDL) and Lisbon groups.
All Women Men
PDL (101) Lisbon (121) PDL (61) Lisbon (59) PDL (40) Lisbon (62)
Age (years) 42± 13 43± 15 42± 13 42± 16 41± 11 44± 15
Male (%) 40 51 — — — —
BMI (kg/m2) 26± 4 26± 6 25± 5 26± 7 27± 3 26± 4
Obesity (%) 14 17 11 19 17 16
Central obesity (%) 35∗ 21 31 27 40 16‡
Waist circumference (cm) 89± 15 87± 14 84± 14 83± 15 97± 11‡ 92± 11
Menopause (%) 33 36 33 36 — —
Current smoker (%) 27 26 26 20 27 32
Current alcohol use (%) 70 66 62 47 81 84
No physical activity (%) 43∗ 28 34 27 56‡ 28
Blood pressure (mmHg)
Systolic BP 121± 17 121± 21 120± 19 116± 22 122± 12 126± 9
Diastolic BP 73± 12∗ 78± 12 72± 13† 77± 13 74± 9‡ 80± 11
Hypertension (%) 30 30 32 31 27 29
Creatinine (mg/dL) 0.83± 0.2∗ 0.78± 0.2 0.74± 0.1† 0.66± 0.1 0.97± 0.1‡ 0.91± 0.1
Urea (mg/dL) 31± 8 32± 9 29± 8 29± 8 34± 7 34± 8
Uric acid (mg/dL) 5.2± 1 5.2± 1 4.5± 1 4.3± 1 6.3± 1 6.1± 1
Glucose (mg/dL) 90± 9∗ 87± 11 88± 9† 84± 10 93± 8‡ 89± 12
Insulin (μU/mL) 10.3± 6 9.2± 5 9.9± 6 8.7± 4 10.9± 5 9.6± 6
HOMA-IR score 2.4± 2∗ 2.0± 1 2.3± 2 1.9± 1 2.5± 1 2.2± 2
HOMA-IR≥ 2.73 (%) 32 21 26 17 40 24
Serum lipids (mg/dL)
TC 197± 34 193± 38 203± 34 197± 43 187± 32 190± 33
HDL-c 60± 19∗ 55± 14 68± 18† 61± 12 48± 13 49± 14
LDL-c 117± 29 121± 35 116± 30 119± 40 119± 29 124± 29
TG 105± 57 105± 54 99± 54 100± 49 113± 60 110± 58
Dyslipidemia (%) 37 41 28 34 50 47
Medicine intake (%)
Oral contraceptives 39∗ 14 39† 14 — —
Statins 16 15 13 17 20 13
Antihypertensives 23 20 23 24 23 16
Antiaggregants 12∗ 3 13† 0 10 5
Values are presented as mean± SD, except otherwise indicated. Figures in parentheses are the number of subjects (n). ∗P< 0.05 for Lisbon group vs. PDL
group; †P< 0.05 for Lisbon women vs. PDL women; ‡P< 0.05 for Lisbon men vs. PDL men.
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0.62± 0.2mg/L in PDL vs 0.66± 0.2mg/L in Lisbon; re-
spectively), but vitamin A did not differ among women
(0.61± 0.2mg/L in PDL vs. 0.61± 0.2mg/L in Lisbon). No
differences were found in these vitamin concentrations
between nonusers vs. users of oral contraceptives.
3.4. Correlation Analysis. As expected, all plasma amino-
thiols correlated with each other, except GSH, which only
correlated with Cys-Gly. Plasma Cys (but not Hcy) was
positively associated with age (r= 0.23; P � 0.001, r= 0.11;
P � 0.114, respectively), while GSH was negatively corre-
lated with age (r=−0.21, P � 0.001). Unsurprisingly, male
gender was associated with higher plasma levels of both Hcy
and Cys-Gly (r= 0.32; P< 0.001, r= 0.19; P< 0.01, re-
spectively), but a similar relationship concerning Cys was
only found in PDL group (r= 0.25; P< 0.05). No relationship
between plasma GSH and gender was registered regardless
the use of oral contraceptives. Furthermore, plasma Cys
levels correlated with BMI (r= 0.22; P � 0.001), waist cir-
cumference (r= 0.31; P< 0.001), menopause (r= 0.23;
P � 0.010), systolic blood pressure (r= 0.25; P< 0.001),
creatinine (r= 0.22; P � 0.001), uric acid (r= 0.22;
P � 0.001), glucose (r= 0.29; P< 0.001), insulin (r= 0.22;
P � 0.001), HOMA-IR (r= 0.26; P< 0.001), folate (r= 0.24;
P< 0.001), and GGT (r= 0.28; P< 0.001), as well as with
vitamin E (r=−0.17; P � 0.013). In turn, plasma Hcy levels
were associated with smoking (r= 0.17; P � 0.013), creati-
nine (r= 0.43; P< 0.001), uric acid (r= 0.40; P< 0.001),
folate (r=−0.30; P< 0.001), vitamin B12 (r=−0.30;
P< 0.001), and GGT (r= 0.22; P< 0.001). On the other hand,
the plasma Hcy level did correlate neither with obesity
parameters nor with those respecting insulin resistance.
3.5.RegressionAnalysis. In order to evaluate the plasma Cys
concentration predictors in all subjects from the two study
groups, regression analyses were performed. In univariate
regression analyses, age, BMI, waist circumference, men-
opause, creatinine, glucose, insulin, systolic BP, folate, and
GGTwere associated with Cys levels. However, when using
a multivariable regression model, only creatinine and folate
concentrations were independently associated with plasma
Cys levels (Table 3). BMI and menopause status were not
included in this model owing to their high collinearity with
waist circumference and age, respectively. However, when
performing the same model to test BMI instead of waist
circumference, no prediction on plasma Cys level was
found. Regression analysis was also applied to test whether
plasma Cys predicted waist circumference (Table 3). In fact,
plasma Cys level was found to predict central obesity but
not BMI (data not shown). Additional adjustment for Cys
confounders (creatinine and folate) increased the signifi-
cance (P � 0.010) of Cys predictive value in waist cir-
cumference. Figure 1 shows the bivariate positive
correlation between plasma Cys and waist circumference in
the study groups.
4. Discussion
4.1. Conventional Risk Factors in the Study Groups. In this
study, PDL and Lisbon groups were age and gender matched
and exhibited a similar prevalence of the conventional
cardiovascular risk factors (dyslipidemia, hypertension,
global obesity, menopausal state, and smoking). )is is in
accordance with Cymbron et al., [27], who already had
reported that the Azores archipelago and mainland Portugal
Table 2: Plasma aminothiol profile and its major determinants in Ponta Delgada (PDL) and Lisbon groups, according to gender.
All Women Men
PDL (101) Lisbon (121) PDL (61) Lisbon (59) PDL (40) Lisbon (62)
Total plasma aminothiols
Cys (μM) 255± 47∗ 185± 44 247± 47† 182± 52 269± 43‡ 188± 36
HCys (%) 18∗ 4 13 5 25 3‡
Hcy (μM) 11± 3∗ 10± 5 10± 3† 8± 3 12± 4‡ 11± 5
HHcy (%) 12 10 8 3 17 16
Cys-Gly (μM) 30± 6∗ 27± 6 29± 6† 26± 6 32± 6‡ 28± 5
GSH (μM) 1.99± 0.6 1.88± 0.7 1.97± 0.6 1.93± 0.8 2.03± 0.6 1.83± 0.6
Substrate/product ratios
Hcy/Cys 0.04± 0.01∗ 0.05± 0.03 0.04± 0.01† 0.05± 0.02 0.05± 0.01‡ 0.06± 0.03
GSH/Cys-Gly 0.07± 0.02 0.07± 0.03 0.07± 0.02 0.08± 0.03 0.06± 0.02 0.07± 0.03
Cys/GSH 140± 53∗ 112± 48 138± 56† 106± 43 144± 48‡ 118± 52
Met/Cys 0.06± 0.02∗ 0.10± 0.04 0.07± 0.02† 0.10± 0.05 0.06± 0.02‡ 0.10± 0.04
Aminothiol determinants
Met (μM) 16± 5 18± 7 16± 6 18± 7 16± 4 19± 7
Folate (ng/mL) 9± 3∗ 8± 3 9± 3 9± 4 9± 3‡ 7± 3
Deficiency (%) 0 3 0 2 0 5
Vit. B12 (pg/mL) 364± 160∗ 445± 168 349± 179† 449± 189 386± 125 440± 146
Deficiency (%) 19∗ 6 21† 5 15 7
Vit. B6 (ng/mL) 17± 10 17± 12 15± 9 15± 5 21± 11 19± 16
Deficiency (%) 6 2 8 3 3 0
GGT activity (U/L) 26± 21∗ 20± 15 21± 17† 14± 6 34± 23 27± 19
Values are presented as mean± SD, except otherwise indicated. Figures in parentheses are the number of subjects (n). HCys, hypercysteinemia; HHcy,
hyperhomocysteinemia. ∗P< 0.05 for Lisbon group vs. PDL group; †P< 0.05 for Lisbon women vs. PDL women; ‡P< 0.05 for Lisbon men vs. PDL men.
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had a similar frequency of risk alleles for dyslipidemia or
hypertension. However, in the present work, men from PDL
revealed to have a more sedentary life with a concomitant
higher waist circumference (central obesity) compared to
those from Lisbon.
Surprisingly, women from PDL had higher HDL-c levels
compared to those from Lisbon. However, it is known that
the use of oral contraceptives (due to the estrogen com-
ponent) increases serum HDL cholesterol [28]. In fact, oral
contraceptives acted as confounders in PDL feminine
gender, by having possibly conferred upon them a better
antioxidant and anti-inflammatory status.
4.2. Hypercysteinemia in PDL Subjects. )e simultaneous
determination of the four aminothiols levels in plasma has
emerged as a useful tool not only for clinical research in-
volving oxidative stress and metabolic and redox regulation
but also for monitoring the disease status [22].
PDL subjects have shown a worse pro-oxidant amino-
thiol profile compared to those from Lisbon, as reflected in
their elevated plasma Cys, Hcy, and Cys-Gly concentrations.
When present in high levels, these three aminothiols (each
onemeasured as the sum of oxidized and reduced forms) can
have pro-oxidant effects [7, 8], through a mechanism in-
volving auto-oxidation and oxidative damage. In fact, their
highly reactive thiol (-SH) group is readily oxidized to form
ROS, like superoxide anion radical (O2−·), and H2O2 in the
vascular wall. In turn, excess of O2−· can lead to the for-
mation of hydroxyl radical (HO·) or react with NO to form
peroxynitrite radical, causing a decrease in NO bio-
availability and consequent endothelial disfunction and
vascular disease [29]. All those reactive species initiate lipid
peroxidation and may induce the oxidation of LDL and
therefore atherosclerosis and CVD events, as previously
referred. )e mean plasma Cys levels found in PDL subjects
(namely, in male gender) were in the high borderline of the
reference interval and similar to those reported by Ӧkzan
et al. [12] and Yardim-Akaydin et al. [30] in CAD patients of
older age.
4.2.1. High Ingestion of Sulfur-Rich Amino Acids. A high
ingestion of sources of sulfur-containing amino acids (Cys
plus Met) like animal protein products (red meat, fish,
poultry, eggs, milk, and dairy products) in PDL could be
partly responsible for these results. In fact, high animal
protein diets, which are rich in Met, have already been
associated with high plasma Hcy and Cys levels [31, 32] and
with increased CAD risk [33, 34]. However, when com-
paring plasma Met content in the study groups, a slightly
lower value was observed in PDL subjects, yet not significant.
A possible reason for this is that blood has been collected
under fasting conditions and Met in PDL subjects is being
overoxidized through the transsulfuration pathway and is
not being preserved by the remethylation one, a situation
that has been reported to occur when there is a high intake of
Met [35]. )is hypothesis corroborates the lower Hcy/Cys
and Met/Cys ratios found in PDL vs. Lisbon subjects.
Furthermore, no differences were found in plasma vi-
tamin B6 levels (an essential dietary cofactor in the trans-
sulfuration pathway) between PDL and Lisbon groups,
which reinforces the presumed high bioavailability of animal
protein in the diet of PDL subjects.
High-protein diets increase urea levels. However, urea
concentrations did not differ between the study groups,
which points to a similar protein intake. Nevertheless, results
suggest that dietary protein of PDL subjects is richer in
sulfur amino acids than that of Lisbon group.
A high ingestion of Met in PDL subjects is also indicated
by their elevated serum creatinine concentration when
compared to Lisbon, which points out to a higher bio-
availability of S-adenosylmethionine (SAM) for creatine
synthesis and creatinine formation in PDL. In fact, dietary
protein consumption (namely, red meat intake) increases
serum creatinine level through protein catabolism [36, 37].
Furthermore, men have higher muscle mass compared to
women, turning them more prone to have higher creatinine
levels (and a consequent altered aminothiol profile), as
shown in the present work (Table 1). Future studies should
evaluate SAM levels (as a better index of Met intake com-
pared to plasma Met) in both populations.
4.2.2. Low Availability of Vitamin B12. PDL subjects also
have exhibited both lower serum vitamin B12 levels and
much higher vitamin B12 deficiency prevalence compared to
those from Lisbon. Low vitamin B12 levels, even within
reference range, have been reported to cause, per se, high
concentrations of folate (5-methyl-tetrahydrofolate), by
diminishing its conversion to tetrahydrofolate and leading to
an inevitable reduction of the Hcy remethylation cycle.
Admitting, as previously described, a higher animal protein
content in the diet of PDL vs. Lisbon subjects, lower levels of
vitamin B12 (with animal protein origin) are suggested to
come from a malabsorption process rather than from an
Table 3: Variables with potential influence on plasma Cys levels or
waist circumference in all subjects from PDL and Lisbon groups,
tested by multiple linear regression analysis.
Variables Standardized β-coefficient P value
Plasma Cys
Age 0.021 0.805
Waist circumference 0.165 0.062
Systolic BP 0.049 0.541
Creatinine 0.182 0.009
Glucose 0.045 0.543
Insulin 0.014 0.863
Folate 0.301 0.001
GGT 0.031 0.669
Waist circumference
Male 0.226 0.001
Age 0.131 0.042
Hypertension 0.138 0.016
Urea 0.046 0.397
Uric acid 0.139 0.036
HOMA-IR 0.376 0.001
Dyslipidemia 0.136 0.011
Cys 0.102 0.034
GGT 0.031 0.570
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inadequate intake. In addition, low vitamin B12 [38] and
high folate levels [39] have already been associated to a
polymorphism in methionine synthase (MTR c.2756A>G),
the enzyme catalyzing the folate-dependent remethylation
pathway of Hcy [40], which has not been investigated in the
present work.
In any case, a low availability of vitamin B12 and the
consequent folate “trapping,” together with a diet rich in
sulfur amino acids (as reected in creatinine levels) seem
likely to be responsible for the hypercysteinemia observed in
PDL subjects (Table 3).
4.3. Hypercysteinemia and Antioxidant Defenses. e
transsulfuration pathway is also redox regulated (at the
level of cystathionine β-synthase) and is upregulated in
situations of oxidative stress, thus favoring GSH synthesis
[41]. However, this was not observed in this study, where
plasma GSH levels were similar in both study groups.
Moreover, there was no correlation between Cys and GSH,
which puts forward that plasma Cys (but not Cys-Gly)
concentrations in excess did not arise from GSH degra-
dation. Also, Cys/GSH ratio was increased in PDL, in-
dicating that plasma Cys concentration exceeded its
requirement for GSH synthesis. Another study also sup-
ports that an excess of Cys in diet does not increase plasma
GSH concentrations [42] but can inhibit its synthesis in-
stead [43]. erefore, the similar GSH levels found in PDL
and Lisbon groups could reect an overconsumption of the
tripeptide in oxidative stress conditions or a decreased GSH
synthesis in PDL subjects, both aecting negatively their
antioxidant defense resources.
Serum GGT activity is regarded as an early marker of
antioxidant inadequacy, even within the reference range
generally accepted [44, 45]. In this study, PDL women have
shown a higher GGT activity compared to those from
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Figure 1: Correlations between plasma Cys level and waist circumference in all subjects from the study groups (a) and by gender (b, c).
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Lisbon, which was correlated with all aminothiols, mainly
GSH. )is last is a well-known relationship, since the main
action of GGT is to metabolize extracellular GSH to produce
Cys and Cys-Gly, thus being the main regulator of their
circulating concentrations [46]. Besides the higher GGT
activity, as well as plasma Cys, Hcy, and Cys-Gly contents in
women from PDL vs. Lisbon, plasma GSH levels were
similar in both groups, regardless the use of oral contra-
ceptives, which corroborates their similar GSH/Cys-Gly
ratios. )is suggests that GGT activity was mainly in-
creased in PDL women for some other reason rather than
GSH degradation, such as the use of antiaggregant therapy
(Table 1).
Regarding male gender, GGT activity (as well as GSH/
Cys-Gly ratio) did not differ between the study groups,
which reinforces the conclusion that this parameter was not
a good early marker of oxidative stress conditions in the
present study. In fact, GGT activity would be expected to be
elevated in men from PDL, owing to their increased pro-
oxidant profile (as evidenced by high levels of plasma Cys,
Hcy, and Cys-Gly). In turn, it is clear that the high Cys levels
in plasma did not arise from GSH degradation (as reflected
in GGT activity), as shown in regression analyses.
4.4. Hypercysteinemia: A Causal Factor for Central Obesity in
Azores? According to the present results, our hypothesis is
that circulating Cys levels (when in high concentrations)
together with a limited physical activity can generate central
obesity, which is hastened by proinflammatory and pro-
oxidant processes derived from HCys. In turn, central
obesity can account for insulin resistance, high blood
pressure, dyslipidemia, and further oxidative stress condi-
tions, thus favoring atherogenesis. In this study, as well as in
others [15, 47–49], plasma Cys is associated with both global
and central obesity and insulin resistance. Several un-
derlying mechanisms are believed to support a causal role of
Cys in obesity. First, high Cys levels have been associated
with decreased energy expenditure via increased Scd-1
(stearoyl-CoA desaturase-1) expression and concomitant
higher SCD-1 activity, a key lipid synthesizing enzyme and
checkpoint in obesity development [50]. Second, Cys can
have pro-oxidant effects, as a result of its auto-oxidation (in a
Cu2+ dependent manner) in plasma by releasing H2O2,
which, through redox cell signaling pathways, inhibits li-
polysis and favors lipogenesis; oppositely, decreased GSH
levels accelerate adipogenesis, since the tripeptide is needed
for glutathione peroxidase activity to scavenge H2O2 [51].
)ird, Cys has insulin-like actions on adipocytes [51], which
favors gene expression of lipogenic and diabetogenic en-
zymes [42].
Interestingly, in the current study, plasma Cys levels
predicted central obesity (waist circumference) but not
global obesity (BMI). Also, several studies have shown the
better predictability of waist circumference over BMI in
assessing the risk of cardiovascular risk factors [52–54]. In
fact, visceral adipose tissue is more metabolically active
and insulin-resistant than subcutaneous adipose tissue.
Women, namely, before menopause, have a more peripheral
subcutaneous distribution of fat (“pear-shaped”) but men-
opause induces a more visceral (“apple-shaped”) distribu-
tion of fat, similar to male gender [55]. )ese sex differences
were well visible in our study, where plasma Cys was a better
predictor of central obesity in men compared to women of
similar age (Figure 1). In turn, central obesity is a major risk
factor to several diseases, including metabolic syndrome,
diabetes mellitus, and CVD [53, 54, 56].
A recent study reported that the Azores archipelago has
the highest (global and central) obesity prevalence in Por-
tugal [57]. Also, official statistical data [58] show that
feminine gender in Azores is the most obese in the country,
supporting our hypothesis of an obesogenic role of hyper-
cysteinemia in Azorean populations.
4.5. Hypercysteinemia and Insulin Resistance. High plasma
Cys (but not Met) has also been reported to be linked to
obesity-related disorders such as metabolic syndrome
components [32, 48], diabetes mellitus [16], and CVD [8].
On the other hand, it is well-known that risk toward
development of diabetes mellitus is high in obese persons.
In the present study, PDL subjects exhibited higher
HOMA-IR score as compared to the Lisbon ones. )is
suggests that high plasma Cys (or central obesity) could
also play a role in insulin sensitivity and related disorders
in these subjects, where the relationship between plasma
fasting glucose and Cys levels was very significant as well
(r � 0.29; P< 0.001). In conditions of excessive Cys levels
(as in PDL subjects), this amino acid is degraded to py-
ruvate, which has the ability to increase glucose levels,
through gluconeogenesis, as usually seen in obesity and
insulin resistance situations.
As is the case of other cross-sectional studies, a cause-
effect association between plasma Cys and central obesity
cannot be derived from the present study. However, there is
substantial evidence in literature that Cys is a causal factor
for obesity and not the reverse [49, 59].
Furthermore, in this study, as shown by regression
analyses, Cys was a determinant of central obesity but central
obesity was not a plasma Cys determinant, which corrob-
orates the hypothesis that elevated Cys concentration is a
cause and not a consequence of obesity.
4.6. Limitations of Lis Study. )is work had several limi-
tations. First, about 40% of PDL women were under taking
oral contraceptives to prevent pregnancy, which was shown
to be a big confounder in some analyses (HDL-c and GSH
levels) and possibly has conferred some protection regarding
the development of central obesity. Second, it was not
possible to determine the methionine synthase activity
(suspicious to be decreased in PDL group) and the respective
polymorphism in these subjects. )ird, unfortunately, data
regarding dietary intake were not available to corroborate
our results. However, it has recently been proved that higher
dietary sulfur-containing amino acids are associated with
higher prevalence of obesity, insulin resistance, and in-
flammation [60].
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5. Conclusions
In conclusion, the prevalence of either standard risk factors
for atherosclerosis or hyperhomocysteinemia is similar in
both study groups. However, PDL subjects (namely, men)
seem to be more prone than those from Lisbon to develop a
pro-oxidant aminothiol profile due to a marked hyper-
cysteinemia, a condition which has been referred to have a
causal role in CVD. )is seems to arise from different be-
havioral and lifestyle factors, namely, an unhealthy diet
(suggested to be highly rich in sulfur amino acids but poor in
fat-soluble antioxidant vitamins) and also a low physical
activity in PDL group. Because diet and lifestyle can also
influence CAD risk, efforts should be done concerning those
items in order to improve CAD primary prevention in the
Azores population.
Assuming that hypercysteinemia is a causal factor for
obesity, PDL subjects (both genders) will be at a potentially
higher risk to suffer from both that condition and related
disorders, namely, insulin resistance and CAD, compared to
those from Lisbon. )erefore, lowering plasma Cys content
(by reducing the ingestion of sulfur-rich amino acids sources
and raising the bioavailability of vitamin B12) is recom-
mended as a preventive strategy to decrease the prevalence
of those diseases in the Azores archipelago.
Data generated from this study allow to partially in-
terpret the higher CAD standardized mortality rate found in
Azores archipelago as compared to mainland. Moreover, it
shows that the plasma aminothiol profile can be an easily
evaluated, precocious, and reliable biomarker of both oxi-
dative stress and related disorders in healthy populations.
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B. Simşek, “)e role of plasma thiol compounds and anti-
oxidant vitamins in patients with cardiovascular diseases,”
Clinica Chimica Acta, vol. 338, no. 1-2, pp. 99–105, 2003.
[31] Y. Xiao, Y. Zhang, M. Wang, X. Li, M. Xia, and W. Ling,
“Dietary protein and plasma total homocysteine, cysteine
concentrations in coronary angiographic subjects,” Nutrition
Journal, vol. 12, no. 1, 144 pages, 2013.
[32] N. Mohorko, A. Petelin, M. Jurdana, G. Biolo, and Z. Jenko-
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